Work

Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal

Year: 2018

Type: article

Source: Molecular Pharmacology

DOI: 10.1124/mol.118.113233

Authors: Ai-Ling Li, Xiaoyan Lin, Amey S. Dhopeshwarkar, Ana Carla Thomaz, Lawrence M. Carey, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Ken Mackie, Andrea G. Hohmann

Institutions: Northeastern University, Indiana University Bloomington, Indiana University

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute on Drug Abuse, National Cancer Institute

Awards: A Novel Mechanism for Decreasing Opioid Reward, NOS1AP as a novel target for treating pathological pain, CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence, Cannabinoid Modulation of Cell Function, Role of CB2 in Analgesic Mechanisms, Structure and Function of CB2 Receptor, INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY, Endocannabinoid Active Sites as Therapeutic Targets

OpenAlex ID: W2902216092

FWCI: 5.16

Cites: 46

Cited by: 69

Related to: 10